Skip to main content
Clinical Trials/NCT06227988
NCT06227988RecruitingNot Applicable

ASSESSMENT OF SURGICAL RISK IN PATIENTS WITH CHRONIC LIVER DISEASE USING VOCAL PENN SCORE

Asian Institute of Gastroenterology, India1 site in 1 country53 target enrollmentStarted: June 20, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
53
Locations
1
Primary Endpoint
To assess postoperative mortality at 30 and 90 days using the VOCAL PENN score

Study Overview

Brief Summary

4a. Primary To assess postoperative mortality at 30 and 90 days using the VOCAL PENN score

4b. Secondary To assess potential differences in prediction accuracy between VOCAL-Penn and MELD for 30 and 90-day mortality

Detailed Description

For each patient and surgery,we will be collecting detailed pre-operative data regarding demographics (age, sex, body mass index, surgery category, comorbidities (diabetes mellitus, hypertension), and pertinent laboratory values (sodium, creatinine, total bilirubin, the international normalized ratio [INR], albumin, platelet count.) The etiology of liver disease will be classified.

To ensure that laboratory data accurately reflected the pre-operative state, only those from within 30 days prior to surgery will be considered For each patient VOCAL PENN score, MELD score, and Mayo score will be calculated using an online calculator.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients with established cirrhosis Patients who had not received liver transplantation and who underwent surgery of interest were included These surgery categories will be the same as those used in the original VOCAL-Penn derivation study and will include the open abdominal, laparoscopic abdominal, and abdominal wall.

Exclusion Criteria

  • •Patients with insufficient pre-operative data to compute the VOCAL-Penn score, Mayo risk score, or MELD-Na score will be excluded.
  • •Patients undergoing liver surgeries Patients who received multiple surgeries Those who didn't give consent

Outcomes

Primary Outcomes

To assess postoperative mortality at 30 and 90 days using the VOCAL PENN score

Time Frame: 2 years

. For comparison between prediction scores receiver operative curves will be used.

Secondary Outcomes

  • To assess potential differences in prediction accuracy between VOCAL-Penn and MELD for 30 and 90-day mortality(2 years)

Investigators

Sponsor
Asian Institute of Gastroenterology, India
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

ASSESSMENT OF SURGICAL RISK IN PATIENTS... | Clinical Trial